Amjad Ali, president, Mullen Lintas Delhi, will be moving on from the agency. Ali has been with the Lintas group for two decades and was part of the founding team of Mullen Lintas.
Ali's next move will see him take the entrepreneurial hat regarding which details are yet to be shared.
Amer Jaleel, group chairman and CCO, MullenLowe Lintas Group, said, “Amjad, an utter and total believer in Lintas, unbelievably leaves us! We had memorable times together. Among Amjad’s extraordinary traits is an ability to project Lintas and especially its creative talent in the best, front-foot forward way. His reputation and ours as a consequence has always been impeccable and I dare say ‘upper class’ in the best, most professional way possible. He’s had a fantastic run with us and for me personally Amjad was always at the striker end taking the bouncers and tiring the bowlers out and letting me take the strike when the ball was ready to be struck!"
Virat Tandon, group CEO, MullenLowe Lintas Group, added, "Over his long tenure of 25 years at Lintas, Amjad has worked on many large businesses and led the teams to do notable work on those brands. He’s been instrumental in setting up and building the Mullen Lintas Delhi office from scratch. I’ve worked very closely with him over the past five years and will miss his 'can do' attitude. After putting so many feathers in his hat at Lintas, he has now decided to step into a totally new world to collect more feathers. I wish him luck with his new venture."
Ali said, "It’s difficult to leave Lintas. It’s an institution, it has a terrific value system. After I finished my Mathematics from one university, I moved into Lintas as another one. It’s like my Alma Mater. So, it’s been a difficult decision all along. But I felt that if there was any correct time to leave, it was this. This is the time to take a new step, yet again, and reset. Hence this decision."
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
12 hours ago
Shortlists announced across Design, Media, Outdoor, and Print and Publishing categories
1 day ago
No show in Pharma Lions